MarketCap
Facebook
X
TelegramQuarterly report 2022-Q4
added 02-09-2023
Quotient Limited P/E Ratio 2011-2026 | QTNT
Annual P/E Ratio Quotient Limited
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.65 | -6.45 | -4.36 | -2.07 | -2.25 | -6.08 | -3.55 | -12.7 | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -1.65 | -12.7 | -4.9 |
P/E Ratio of other stocks in the Diagnostics research industry
| Issuer | P/E Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Agilent Technologies
A
|
34.7 | $ 110.24 | -2.87 % | $ 33.5 B |  USA |
 |
Centogene N.V.
CNTG
|
-10.3 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Enzo Biochem
ENZ
|
-0.00221 | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
-93.8 | - | - | $ 19.8 B | USA |
|
Akumin
AKU
|
-0.479 | - | -17.87 % | $ 25.9 M |  Canada |
|
Biodesix
BDSX
|
-2.14 | $ 14.21 | -2.67 % | $ 1.84 B | USA |
 |
Biomerica
BMRA
|
-1.45 | $ 2.01 | -4.74 % | $ 4.62 M | USA |
 |
Burning Rock Biotech Limited
BNR
|
-7.25 | $ 16.36 | -11.57 % | $ 176 M |  China |
 |
Sotera Health Company
SHC
|
61 | $ 13.13 | -3.03 % | $ 3.73 B | USA |
 |
Brainsway Ltd.
BWAY
|
-37.1 | $ 12.87 | -4.6 % | $ 99.4 M |  Israel |
 |
Celcuity
CELC
|
-30.3 | $ 106.02 | -7.66 % | $ 4.96 B | USA |
 |
Check-Cap Ltd.
CHEK
|
-0.172 | - | - | $ 9.42 M | Israel |
 |
DarioHealth Corp.
DRIO
|
-0.787 | $ 8.11 | -4.02 % | $ 32.3 M | Israel |
 |
Heska Corporation
HSKA
|
-42.4 | - | - | $ 1.31 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-233 | - | - | $ 562 M |  Britain |
 |
BioNano Genomics
BNGO
|
-0.301 | $ 1.16 | 0.87 % | $ 6.32 M | USA |
 |
DermTech
DMTK
|
-0.421 | - | -11.32 % | $ 2.94 M | USA |
 |
Aspira Women's Health
AWH
|
-1.67 | - | -6.19 % | $ 10.5 M | USA |
 |
DexCom
DXCM
|
30.5 | $ 62.25 | -5.81 % | $ 24.3 B | USA |
 |
Accelerate Diagnostics
AXDX
|
-2.76 | - | -61.36 % | $ 2.46 M | USA |
 |
Global Cord Blood Corporation
CO
|
0.485 | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
-9.08 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-1.29 K | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-3.07 | - | 0.12 % | $ 80.1 M | China |
 |
HTG Molecular Diagnostics
HTGM
|
-0.138 | - | -20.0 % | $ 1.06 M | USA |
 |
Castle Biosciences
CSTL
|
38.9 | $ 23.53 | -4.74 % | $ 654 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
39.9 | - | - | $ 10.7 B | USA |
 |
Charles River Laboratories International
CRL
|
-53.3 | $ 159.16 | -3.62 % | $ 7.89 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
23.5 | $ 195.51 | -1.22 % | $ 21.7 B | USA |
 |
Organovo Holdings
ONVO
|
-1.25 | - | -2.3 % | $ 19.4 M | USA |
 |
OpGen
OPGN
|
0.761 | - | -16.95 % | $ 1.54 M | USA |
 |
Guardant Health
GH
|
-32.3 | $ 84.61 | -3.96 % | $ 10.6 B | USA |
 |
Biocept
BIOC
|
-0.185 | - | -13.05 % | $ 7.29 M | USA |
 |
ICON Public Limited Company
ICLR
|
21 | $ 102.08 | -0.97 % | $ 8.42 B |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
48.3 | $ 558.32 | -2.61 % | $ 44.9 B | USA |
 |
Illumina
ILMN
|
-13.4 | $ 117.67 | -5.41 % | $ 18.7 B | USA |
 |
PerkinElmer
PKI
|
52.3 | - | -0.91 % | $ 14.7 B | USA |
 |
Invitae Corporation
NVTA
|
-5.12 | - | - | $ 21.2 M | USA |
 |
IQVIA Holdings
IQV
|
20.8 | $ 163.85 | -3.28 % | $ 28.2 B | USA |
 |
Interpace Biosciences
IDXG
|
0.615 | $ 1.68 | -2.89 % | $ 7.37 M | USA |
 |
Motus GI Holdings
MOTS
|
-0.0769 | - | -34.28 % | $ 263 K | Israel |
 |
QIAGEN N.V.
QGEN
|
102 | - | - | $ 10.6 B |  Niderland |
 |
Neogen Corporation
NEOG
|
-0.933 | $ 8.7 | -4.92 % | $ 1.89 B | USA |
 |
Chembio Diagnostics
CEMI
|
-0.54 | - | 0.22 % | $ 16.8 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
27.3 | $ 264.2 | -1.56 % | $ 22 B | USA |
 |
Psychemedics Corporation
PMD
|
-4.05 | - | -1.84 % | $ 15.3 M | USA |
 |
Precipio
PRPO
|
-1.49 | $ 25.97 | -4.52 % | $ 33.7 M | USA |
 |
CareDx, Inc
CDNA
|
-46.5 | $ 16.78 | -3.95 % | $ 894 M | USA |
 |
Syneos Health
SYNH
|
39.8 | - | - | $ 4.46 B | USA |